Myriad Genetics Launches New Vectra® Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis

NEXT STORY
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
PREV STORY
MATEON ANNOUNCES COMPLETION OF ARTI-19 AND PUBLICATION OF POSITIVE INTERIM DATA
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adaptimmune Presents Detailed Safety Update from Ongoing MAGE-A10 Pilot Studies at ASCO

- Acceptable safety profile with no evidence of off-target toxicity in 100 million cell ...

author_avatar
NASDAQ Market News

Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations

author_avatar
NASDAQ Market News

pMD Announces Instant Capture for Lighting Fast Mobile Charge Capture in Seconds

author_avatar
NASDAQ Market News